Heinrich Dreismann and Harry Glorikian

In a filing with the US Securities and Exchange Commission, Interpace Diagnostics announced the resignations of Heinrich Dreismann and Harry Glorikian from the company's board of directors. The company stated that neither resignation was due to a disagreement with the company or matters relating to the company's operations, policies, or practices.